Cutera, Inc. (CUTR)
- Previous Close
2.0400 - Open
2.0600 - Bid 2.1100 x 400
- Ask 2.1400 x 300
- Day's Range
2.0150 - 2.2500 - 52 Week Range
1.2800 - 23.2800 - Volume
702,340 - Avg. Volume
1,056,053 - Market Cap (intraday)
42.316M - Beta (5Y Monthly) 1.67
- PE Ratio (TTM)
-- - EPS (TTM)
-5.7600 - Earnings Date May 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.33
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
www.cutera.comRecent News: CUTR
Performance Overview: CUTR
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CUTR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CUTR
Valuation Measures
Market Cap
42.32M
Enterprise Value
292.91M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.18
Price/Book (mrq)
--
Enterprise Value/Revenue
1.27
Enterprise Value/EBITDA
-3.09
Financial Highlights
Profitability and Income Statement
Profit Margin
-71.02%
Return on Assets (ttm)
-20.32%
Return on Equity (ttm)
--
Revenue (ttm)
212.37M
Net Income Avi to Common (ttm)
-150.83M
Diluted EPS (ttm)
-5.7600
Balance Sheet and Cash Flow
Total Cash (mrq)
143.61M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-114.45M
Research Analysis: CUTR
Company Insights: CUTR
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: CUTR
CUTR: Lowering target price to $13.00
CUTERA INC has an Investment Rating of SELL; a target price of $13.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetCUTR: Raising target price to $15.00
CUTERA INC has an Investment Rating of SELL; a target price of $15.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetCUTR: What does Argus have to say about CUTR?
CUTERA INC has an Investment Rating of SELL; a target price of $13.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetCUTR: What does Argus have to say about CUTR?
CUTERA INC has an Investment Rating of SELL; a target price of $13.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice Target